RxDoctor Payments DataLook up a doctor →

CARDIVA VASCADE MVP XL VVCS 10-12F: payments to doctors

Payments that named CARDIVA VASCADE MVP XL VVCS 10-12F as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Total reported
$124K
Providers
1,145
Transactions
1,916
Average per transaction
$65

The per-transaction average — $65 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,145 providers the average total is $109, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Cardiva Medical, Inc.$115,26992.7%
Haemonetics Corporation$9,1197.3%
← All drugs & devices